Trump’s Drug Price Deals: 3-Year Limit Revealed | STAT
Trump’s Drug Pricing Deals: A Three-Year Window for Change? President Trump’s push for lower prescription drug prices, often touted through “most-favored nation” (MFN) deals with pharmaceutical companies, continues to be a subject of scrutiny. Recent Securities and Exchange Commission (SEC) filings reveal a key detail previously undisclosed: at least some of these agreements are set … Read more